How Children can beat 'The Virus'
We are talking to children about a germ (The Virus) that makes people sick.We know how to beat this virus. Listen to what Gru says.
Here is a fun story told by Gru about how to be safe from the virus.
You can just click the picture to start the movie.
Do Minions Catch The Virus? Not if they do these things. Hey kids. Funny Minions, silly GRU, some moms, doctors and nurses explain social distancing, hand washing and getting a needle vaccine.
|Saint Kitts and Nevis||44||-||44|
|British Virgin Islands||194||1||183||10|
|Isle of Man||1584||29||1545||10|
|Sahrawi Arab DR||34||3||27||4|
|Saint Pierre Miquelon||25||-||24||1|
|Sao Tome and Principe||2292||35||2227||30|
|Turks and Caicos||2375||17||2326||32|
|US Virgin Islands||3068||27||2984||57|
Text in Image for parents and kids: SARS-CoV-2, influenza (the flu), endemic smallpox, polio, measles, pertussis & rubella are vaccine-preventable disease only if all humans maintain the resistance. Some disease are spreading because of never-established or waning immunity. That's the case for universal immunization and keeping the human race well and healthy. Please keep the children's vaccinations, and yours, up-to-date during these difficult times. The vaccines under development for the germ (a coronavirus) that causes COVID-19 disease, are doing a good job for the people who have taken them. Soon they will be available to everyone. Photo Credit: Melissa Hemingway/Feminine-Perspective Magazine
Seventy-five countries have submitted expressions of interest to protect their populations and those of other nations through joining the COVAX Facility, a mechanism designed to guarantee rapid, fair and equitable access to COVID-19 vaccines worldwide.
The 75 countries, which would finance the vaccines from their own public finance budgets, partner with up to 90 lower-income countries that could be supported through voluntary donations to Gavi's COVAX Advance Market Commitment (AMC). Together, this group of up to 165 countries represents more than 60% of the world's population. Among the group are representatives from every continent and more than half of the world's G20 economies.
COVAX is the only truly global solution to the COVID-19 pandemic," said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance. For the vast majority of countries, whether they can afford to pay for their own doses or require assistance, it means receiving a guaranteed share of doses and avoiding being pushed to the back of the queue, as we saw during the H1N1 pandemic a decade ago. Even for those countries that are able to secure their own agreements with vaccine manufacturers, this mechanism represents, through its world-leading portfolio of vaccine candidates, a means of reducing the risks associated with individual candidates failing to show efficacy or gain licensure."
"The COVAX Facility forms a key part of the COVAX pillar (COVAX) of the Access to COVID-19 Tools (ACT) Accelerator, a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO, working in partnership with developed and developing country vaccine manufacturers. COVAX aims to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access for every country in the world," says Dr. Tedros of the World Health Organization.
"It will achieve this by sharing the risks associated with vaccine development, investing in manufacturing upfront so vaccines can be deployed at scale as soon as they are proven successful, and pooling procurement and purchasing power to achieve sufficient volumes to end the acute phase of the pandemic by 2021."
This early level of interest represents a tremendous vote of confidence in COVAX and our shared goal to protect people around the globe through the fair allocation of a COVID-19 vaccine," said Dr Richard Hatchett, CEO of CEPI. COVAX offers an innovative solution to the gravest public health crisis in living memory. It will speed up the availability of safe and effective vaccines through early investment in manufacturing capacity, and maximise the chances of success by backing a broad and diverse portfolio of vaccine candidates. Through COVAX our aspiration is to be able to vaccinate the most vulnerable 20% of the population of every country that participates, regardless of income level, by the end of 2021. Ensuring fair access is not only a matter of equity; it is the fastest way to end this pandemic"Read more at the WHO Vaccination Project.